Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Lawrence Durban

Thoracic Surgery (Cardiothoracic Vascular Surgery) West Islip, NY Medical Doctor

NPI 1346358173 CMS profile 242928

1111 Montauk Highway, 3Rd Floor, West Islip, NY 11795

Open in the dashboard

General payments

$141,672

734 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Lawrence Durban of West Islip, NY is reported in the CMS Open Payments database as having received $141,672 across 734 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,896 119
2024 General $5,821 78
2023 General $25,876 108
2022 General $13,052 95
2021 General $11,429 111
2020 General $43,015 109
2019 General $33,584 114

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lawrence Durban
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Lawrence Durban were reported at $8,896. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Lawrence Durban Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $33,584 $886 $178–$3,167 $163
2020 $43,015 $341 $108–$1,605 $114
2021 $11,429 $453 $125–$1,886 $132
2022 $13,052 $695 $180–$2,566 $149
2023 $25,876 $745 $205–$2,662 $160
2024 $5,821 $799 $214–$2,967 $164
2025 $8,896 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $91,077 399 payments
  2. Philips Electronics North America Corporation $37,193 141 payments
  3. Atricure, Inc. $3,665 55 payments
  4. Ethicon Inc. $2,318 13 payments
  5. Medtronic, Inc. $1,992 28 payments
  6. Intuitive Surgical, Inc. $1,623 5 payments
  7. Boston Scientific Corporation $1,520 56 payments
  8. Kestra Medical Technology Services, Inc. $606 6 payments
  9. Noah Medical Corporation $192 2 payments
  10. Covidien LP $172 2 payments
  11. Other $1,314 27 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $96,329 72 payments
  2. Food and Beverage $28,059 630 payments
  3. Travel and Lodging $9,890 29 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,394 3 payments
Products named General payments · program years 2019–2025
  1. Endurity Pacemaker $23,612 22 payments
  2. (9520) IGT Devices Undivided $14,920 6 payments
  3. Quadra Allure MP RF CRT Pacemkr $12,440 9 payments
  4. Anthem CRT Pacemaker $9,794 8 payments
  5. ALLURE $8,279 11 payments
  6. ACCENT $8,041 7 payments
  7. CVX-300 $7,200 2 payments
  8. Allure Quadra RF CRT Pacemaker $5,418 7 payments
  9. Quadra Assura CRT Defibrillator $4,790 26 payments
  10. ALLURE QUADRA $3,943 6 payments
  11. Other $45,225 648 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 88 billing codes

Paid by Medicare

$329,323

Medicare's payments for the services billed

Medicare patients

447

Average age 78

Services billed

1,393

183 women, 264 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 62%
Arthritis 61%
Atrial fibrillation 54%
Diabetes 52%
COPD 43%
Chronic kidney disease 40%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
KEYTRUDA
  • Merck Sharp & Dohme Corporation $24
$24 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

734 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record